These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19412489)

  • 1. Pramipexole: new use for an old drug - the potential use of pramipexole in the treatment of restless legs syndrome.
    Benbir G; Guilleminault C
    Neuropsychiatr Dis Treat; 2006 Dec; 2(4):393-405. PubMed ID: 19412489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron for the treatment of restless legs syndrome.
    Trotti LM; Becker LA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007834. PubMed ID: 30609006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
    Montplaisir J; Denesle R; Petit D
    Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome: differential diagnosis and management with pramipexole.
    Brindani F; Vitetta F; Gemignani F
    Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose pramipexole in the management of restless legs syndrome. An open label trial.
    Stiasny-Kolster K; Oertel WH
    Neuropsychobiology; 2004; 50(1):65-70. PubMed ID: 15179023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restless legs syndrome in the older adult: diagnosis and management.
    Milligan SA; Chesson AL
    Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restless legs syndrome: treatment with dopaminergic agents.
    Comella CL
    Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonists for restless legs syndrome.
    Scholz H; Trenkwalder C; Kohnen R; Riemann D; Kriston L; Hornyak M
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD006009. PubMed ID: 21412893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of restless legs syndrome in patients on dialysis.
    Molnar MZ; Novak M; Mucsi I
    Drugs; 2006; 66(5):607-24. PubMed ID: 16620140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).
    Winkelman JW; Johnston L
    Sleep Med; 2004 Jan; 5(1):9-14. PubMed ID: 14725821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pramipexole in the management of restless legs syndrome: an extended study.
    Silber MH; Girish M; Izurieta R
    Sleep; 2003 Nov; 26(7):819-21. PubMed ID: 14655914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current treatment options for restless legs syndrome.
    Wetter TC; Winkelmann J; Eisensehr I
    Expert Opin Pharmacother; 2003 Oct; 4(10):1727-38. PubMed ID: 14521483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes.
    Winlow W
    Core Evid; 2005; 1(1):35-42. PubMed ID: 22496675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer dopamine agonists in the treatment of restless legs syndrome.
    Weimerskirch PR; Ernst ME
    Ann Pharmacother; 2001 May; 35(5):627-30. PubMed ID: 11346069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation in patients with restless legs syndrome receiving pramipexole therapy: a retrospective study in a single center from China.
    Wang T; Ying M; Zhao R; Zhu D; Zhang L
    Sleep Breath; 2022 Mar; 26(1):373-380. PubMed ID: 33864178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High national rates of high-dose dopamine agonist prescribing for restless legs syndrome.
    Winkelman JW
    Sleep; 2022 Feb; 45(2):. PubMed ID: 34417810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First night efficacy of pramipexole in restless legs syndrome and periodic leg movements.
    Manconi M; Ferri R; Zucconi M; Oldani A; Fantini ML; Castronovo V; Ferini-Strambi L
    Sleep Med; 2007 Aug; 8(5):491-7. PubMed ID: 17512780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for restless legs syndrome.
    Ferini-Strambi L
    Expert Opin Pharmacother; 2009 Mar; 10(4):545-54. PubMed ID: 19284359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
    Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
    Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.